Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Phase III Clinical Trials
Overview
Market size
$32.0B
global, USD
CAGR
6.8%
base to forecast
Buyer power
-1.4
supplier-favoured
Suppliers
7
tracked players
Signals
12
6 high severity
Market outlook
2031$44.5B
What changed
Demand by region
North America demand50%
Europe demand25%
Asia Pacific demand18%
Rest of world demand7%
share of global demandtotal 100%
Cost drivers
Clinical investigator and coordinator site fees35%
In-house project management and clinical monitoring staff25%
Patient recruitment, retention, and decentralized trial logistics15%
Data management, biostatistics, and advanced digital platforms15%
Regulatory affairs, medical writing, and quality compliance10%
share of delivered cost (analyst estimate)